{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:05:44Z","timestamp":1778544344963,"version":"3.51.4"},"reference-count":18,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.3892\/mco.2013.146","type":"journal-article","created":{"date-parts":[[2013,7,12]],"date-time":"2013-07-12T09:06:54Z","timestamp":1373620014000},"page":"911-917","source":"Crossref","is-referenced-by-count":5,"title":["Significance of clinical factors as prognostic indicators for patients with peripheral T-cell non-Hodgkin lymphoma: A retrospective analysis of 252 cases"],"prefix":"10.3892","volume":"1","author":[{"given":"WANZHUO","family":"XIE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEYUE","family":"HU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FAN","family":"XU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DE","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WEIJIA","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JINGSONG","family":"HE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIMIN","family":"SHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YI","family":"LUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIE","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAOFANG","family":"LIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIUJIN","family":"YE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHEN","family":"CAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HE","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,7,12]]},"reference":[{"key":"key20180107151716_b1-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/cncr.22507","article-title":"Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma","volume":"109","author":"Tomita","year":"2007","journal-title":"Cancer"},{"key":"key20180107151716_b2-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.leukres.2004.04.016","article-title":"Clinicopathological features and prognostic factors of Japanese patients with \u2018peripheral T-cell lymphoma, unspecified\u2019 diagnosed according to the WHO classification","volume":"28","author":"Kojima","year":"2004","journal-title":"Leuk Res"},{"key":"key20180107151716_b3-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1008200307625","article-title":"Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L","volume":"8","author":"Ascani","year":"1997","journal-title":"Classification Ann Oncol"},{"key":"key20180107151716_b4-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1200\/JCO.1989.7.12.1783","article-title":"Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin\u2019s lymphoma","volume":"7","author":"Armitage","year":"1989","journal-title":"J Clin Oncol"},{"key":"key20180107151716_b5-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107151716_b6-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) trials","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"key":"key20180107151716_b7-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hon.853","article-title":"Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas","volume":"26","author":"Niitsu","year":"2008","journal-title":"Hematol Oncol"},{"key":"key20180107151716_b8-mco-01-05-0911","first-page":"659","article-title":"Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation","volume":"6","author":"Siegert","year":"1995","journal-title":"The Kiel Lymphoma Study Group Ann Oncol"},{"key":"key20180107151716_b9-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"key20180107151716_b10-mco-01-05-0911","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th edition"},{"key":"key20180107151716_b11-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"key20180107151716_b12-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","article-title":"Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma","volume":"15","author":"Ansell","year":"1997","journal-title":"J Clin Oncol"},{"key":"key20180107151716_b13-mco-01-05-0911","first-page":"76","article-title":"Prognostic significance of T-cell phenotype in aggressive non-Hodgkin\u2019s lymphomas","volume":"92","author":"Gisselbrecht","year":"1998","journal-title":"Blood"},{"key":"key20180107151716_b14-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","article-title":"Peripheral T-cell lymphomas: Initial features, natural history and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. classification","volume":"9","author":"L\u00f3pez-Guillermo","year":"1998","journal-title":"Ann Oncol"},{"key":"key20180107151716_b15-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1200\/JCO.1992.10.2.219","article-title":"MACOP-B treatment in diffuse large-cell lymphoma: identification of prognostic groups in an Italian multicenter study","volume":"10","author":"Vitolo","year":"1992","journal-title":"J Clin Oncol"},{"key":"key20180107151716_b16-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1200\/JCO.1991.9.2.236","article-title":"Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse","volume":"9","author":"Robertson","year":"1991","journal-title":"J Clin Oncol"},{"key":"key20180107151716_b17-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ajcp\/86.4.449","article-title":"Bone marrow manifestation of peripheral T-cell lymphoma: a study of 30 cases","volume":"86","author":"Hanson","year":"1986","journal-title":"Am J Clin Pathol"},{"key":"key20180107151716_b18-mco-01-05-0911","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/oxfordjournals.annonc.a058324","article-title":"A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the \u2018tumor score\u2019","volume":"3","author":"Rodriguez","year":"1992","journal-title":"Ann Oncol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2013.146\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T15:18:00Z","timestamp":1515338280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2013.146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,12]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,7,12]]},"published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.3892\/mco.2013.146"],"URL":"https:\/\/doi.org\/10.3892\/mco.2013.146","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,12]]}}}